Older adults who suffer from heart failure with preserved ejection fraction (HFpEF) are frequently prescribed beta-blockers despite limited data to show their benefit in HFpEF . Moreover, there is evidence suggesting that these agents can worsen geriatric conditions in this population by exacerbating chronotropic incompetence.
Dr Brian Yum (Weill Cornell Medicine, USA) and colleagues examined a subset of data from the REasons for Geographic and Racial Differences in Stroke (REGARDS) study. REGARDS is an observational, population-based cohort study including 30,000 individuals aged ≥45 years designed to identify factors that contribute to the excess stroke mortality in Southeastern USA and in African Americans. Yum et al. examined 316 adults aged >65 years with an adjudicated HFpEF hospitalisation to gain insights into indications for beta-blockers use among older adults hospitalised with HFpEF. The presence of a history of myocardial infarction (MI),...
please login to read the entire article:
You need to register to read the entire article, please do so now.
« Clopidogrel monotherapy after 1-month DAPT may be beneficial in stent patients Next Article
Immediate angiography not better than delayed angiography in non-STEMI cardiac arrest patients »
Table of Contents: ACC 2019
Acute and Stable Ischaemic Heart Disease
Arrhythmias and Clinical Electrophysiology
Congenital Heart Disease
Heart Failure and Cardiomyopathies
Pulmonary Arterial Hypertension and Venous Thromboembolism
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.